Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trialHarold Atkins, Mark S. Freedman, Isabelle Bence‐Bruckler et al.|The Lancet|2016Cited by 327
Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR OutcomesChristopher R. Flowers, Edmund K. Waller, Luciano J. Costa et al.|Transplantation and Cellular Therapy|2016Cited by 24
Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR OutcomesCésar O. Freytes, Ian W. Flinn, Isabelle Bence‐Bruckler et al.|DukeSpace (Duke University)|2020Cited by 0